Important note: Information in this article was accurate in 2004. The state of the art may have changed since the publication date.
Important note: Information in this article was accurate in 2004. The state of the art may have changed since the publication date.
Reuters NewMedia - November 26, 2004
Officials have pledged to speed up the approval process for anti-AIDS drugs in China, where the United Nations has warned AIDS victims could rise to 10 million by 2010 unless serious steps are taken to fight the epidemic.
"Researchers infected a monkey with the AIDS virus after injecting the compound vaccine into its body, and found no abnormal reactions occurred," Xinhua quoted the State Food and Drug Administration of China as saying.
The International AIDS Vaccine Initiative has said dozens of potential vaccines are being tested and more than 70 human clinical trials have taken place although none had yet promised to conquer the virus.
China, which has been reluctant to acknowledge the spread of the disease, has also pledged to strengthen surveillance of HIV/AIDS and to begin nationwide HIV testing among people who have sold blood.
Whole villages in the central province of Henan were infected when millions sold blood to unsanitary clinics in the 1990s, although authorities say the country has fewer than 1 million HIV carriers and about 80,000 with full-blown AIDS.
"We will also search for HIV carriers among prisoners and people in the drug abstention house," Xinhua quoted Vice Health Minister Gao Qiang as saying.
Last year on World AIDS Day, Premier Wen Jiabao shook hands with AIDS patients at a Beijing hospital in a symbolic display of commitment to fighting the disease.
But efforts to step up AIDS prevention remain shackled by politics and by conservative attitudes toward sex.
Last week, university authorities halted a plan to distribute free condoms on Beijing campuses, saying students should be educated against pre-marital sex.
041126
RE041156
Copyright © 2004 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .